Northwest Biotherapeutics Stock Price on December 4, 2024
| NWBO Stock | USD 0.28 0.01 3.70% |
If you're considering investing in Northwest OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Northwest Biotherapeutics stands at 0.28, as last reported on the 4th of December, with the highest price reaching 0.30 and the lowest price hitting 0.27 during the day. Northwest Biotherapeutics has Sharpe Ratio of -0.0091, which conveys that the firm had a -0.0091% return per unit of risk over the last 3 months. Northwest Biotherapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Northwest Biotherapeutics' Risk Adjusted Performance of (0.01), mean deviation of 2.57, and Standard Deviation of 3.85 to check out the risk estimate we provide.
Northwest OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Northwest |
Sharpe Ratio = -0.0091
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NWBO |
Estimated Market Risk
| 3.9 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Northwest Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Northwest Biotherapeutics by adding Northwest Biotherapeutics to a well-diversified portfolio.
Northwest Biotherapeutics Valuation on December 4, 2024
It is possible to determine the worth of Northwest Biotherapeutics on a given historical date. On December 4, 2024 Northwest was worth 0.28 at the beginning of the trading date compared to the closed value of 0.28. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Northwest Biotherapeutics otc stock. Still, in general, we apply an absolute valuation method to find Northwest Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Northwest Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Northwest Biotherapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.27 | 0.28 | 0.27 | 0.28 | 839,637 | |
12/04/2024 | 0.28 | 0.30 | 0.27 | 0.28 | 932,497 |
| Backtest Northwest Biotherapeutics | | | Northwest Biotherapeutics History | | | Northwest Biotherapeutics Valuation | Previous |
Northwest Biotherapeutics Trading Date Momentum on December 4, 2024
| On December 04 2024 Northwest Biotherapeutics was traded for 0.28 at the closing time. The top price for the day was 0.30 and the lowest listed price was 0.27 . The trading volume for the day was 932.5 K. The trading history from December 4, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Northwest Biotherapeutics Fundamentals Correlations and Trends
By evaluating Northwest Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Northwest Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Northwest financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Northwest Biotherapeutics OTC Stock history
Northwest Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Northwest is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Northwest Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Northwest Biotherapeutics stock prices may prove useful in developing a viable investing in Northwest Biotherapeutics
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company was founded in 1996 and is headquartered in Bethesda, Maryland. Northwest Bioth operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 19 people.
Northwest Biotherapeutics OTC Stock Technical Analysis
Northwest Biotherapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Northwest Biotherapeutics Period Price Range
Low | December 4, 2024
| High |
0.00 | 0.00 |
Northwest Biotherapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Northwest Biotherapeutics December 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Northwest Biotherapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Northwest Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Northwest Biotherapeutics otc stock market strength indicators, traders can identify Northwest Biotherapeutics entry and exit signals to maximize returns
Northwest Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Northwest Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Northwest OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Northwest to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (0.13) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Northwest OTC Stock
Northwest Biotherapeutics financial ratios help investors to determine whether Northwest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Northwest with respect to the benefits of owning Northwest Biotherapeutics security.